-The Hindu More than a year after 13 women died in a mass sterilisation camp in Chhattisgarh, it is far from clear whether lessons have been learnt or justice done Sixteen months after a mass sterilisation camp conducted by the government of Chhattisgarh resulted in 13 deaths and 65 injuries, viscera reports — from the Central Forensic Science Laboratory in Ramanthapur, Hyderabad, and from the Central Drugs Laboratory, Kolkata, to go with...

-The Economic Times   I will never make the mistake of discontinuing M(G)NREGA; because it is a living testimony of your failures. After 60 years of Independence you had to make people dig ditches — Prime Minister Narendra Modi. In that March 2015 speech in Parliament, Prime Minister Modi taunted the Congress Party that the rural job guarantee programme Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS) was required because of the party's...

-People’s Democracy In the last week of February, a panel set up by the WTO’s Dispute Settlement Body ruled against India on a complaint by the US in early 2013 that India’s Domestic Content Requirement (DCR) for some solar power projects violated WTO prohibitions on measures that result in “less favourable treatment” of international trade partners. The panel was ruling on an appeal by India in response to the original injunction...

-Kafila.org The last few months have seen an unusual public engagement around questions of secularism, freedom of speech, sedition and the like, with furious debates everywhere from our campuses, streets and TV studios to the floor of Parliament. The budget session has been enlivened by scenes of high drama, with the leading lights of the Treasury benches bringing colour, sound and fury to their tutorials on patriotism and nationalism. While these high-decibel...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...